IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)
New Form 8-K - Enliven Therapeutics, Inc. Filed: 2025-06-16 AccNo: 0001193125-25-141085 Size: 629 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
There are no comments here yet...